Multiple sclerosis patients treated with intramuscular IFN-beta-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction

Raymond Hupperts*, Veit Becker, Janne Friedrich, Claudio Gobbi, Antonio Vasco Salgado, Bjorn Sperling, Xiaojun You

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)15-25
JournalExpert Opinion on Drug Delivery
Issue number1
Publication statusPublished - Jan 2015


  • clinical trial
  • IFN-beta-1a
  • medication adherence
  • multiple sclerosis
  • Phase IV
  • self-administration

Cite this